Clinical Trials Directory

Trials / Completed

CompletedNCT02311075

Mechanisms of Endothelial Dysfunction in Type 2 Diabetes

Determination of the Mechanisms Involved in Conduit Artery Endothelial Dysfunction in Type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
University Hospital, Rouen · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

Endothelial dysfunction of conduit arteries plays an important role in the development of cardiovascular complications associated with type 2 diabetes. In order to propose targeted therapeutic approaches, this study aim to determine the mechanisms involved in endothelial dysfunction of conduit arteries in these patients.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood samplesBlood samples will be performed at baseline and during endothelial stimulation by hand skin heating to quantify metabolites of NO, EETs, ET-1 and ROS

Timeline

Start date
2014-12-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2014-12-08
Last updated
2017-06-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02311075. Inclusion in this directory is not an endorsement.

Mechanisms of Endothelial Dysfunction in Type 2 Diabetes (NCT02311075) · Clinical Trials Directory